Developer docs
API playgroundTry for free, no card

Search company profiles

InfuSystem Holdings

Full company profile

uuid0009tkd

Namestring
InfuSystem Holdings
Legal namestring
InfuSystem, Inc.
Websiteurl
infusystem.com
Company typeenum
Public
Founded yearint
1985
Descriptiontext

InfuSystem Holdings, Inc. (NYSE: INFU) is a national healthcare service provider that delivers integrated therapy services, biomedical repair and maintenance, and durable medical equipment (DME) to healthcare providers, DME manufacturers, and patients across the United States and Ontario, Canada. Operating for approximately 40 years and headquartered in Rochester Hills, Michigan, the company is structured around three reporting segments: Patient Services (recurring DME rentals focused on oncology, pain management, and wound care), Device Solutions (one-time sales of new and pre-owned ambulatory and pole-mounted infusion pumps, disposables, and accessories), and Biomedical Services (on-site and depot repair of infusion pumps, patient monitors, ESUs, and related equipment). Its primary customer base spans hospitals, oncology practices, pain management clinics, wound care providers, and DME manufacturers. In FY2025 the company generated record revenue of $143.4 million (+6% YoY), record adjusted EBITDA of $31.5 million (+24% YoY), and record operating cash flow of $24.4 million (+19% YoY), with a Q4 2025 adjusted EBITDA margin of 24.3%.

The company has built a proprietary technology stack including DeviceHub® for medical device lifecycle management, Express™ for patient and facility billing, and the InfuBLOCK Dashboard™ for therapy monitoring — platforms that integrate equipment tracking, maintenance scheduling, and reimbursement workflows into a single operational layer for healthcare providers. The product portfolio covers a broad catalog of FDA-registered ambulatory infusion pumps (CADD, Curlin, Sapphire, BodyGuard), large-volume pole-mounted pumps (BD Alaris, Plum 360, SIGMA Spectrum), syringe and enteral pumps, NPWT wound care systems, the Home First® Wound Care Kit, Safen® single-use line identification tags (recognized as the industry standard for infusion line labeling), the Chemo Mouthpiece, and the Radiaderm® radiation therapy skincare line. A new ERP system was implemented on March 1, 2026, with management projecting approximately $2 million in annual net savings. Distribution is delivered through six regional Centers of Excellence across Michigan, Kansas, California, Massachusetts, Texas, and Ontario, supported by direct field sales representatives.

The revenue model combines recurring monthly DME rental income, one-time equipment and consumable sales, and professional service fees for biomedical maintenance and billing/insurance support. Pricing is predominantly quote-based for commercial business, with Medicare patient treatment pricing standardized at $79.00 per treatment. Go-to-market is sales-led, targeting hospitals, clinics, oncology practices, pain management practices, wound care providers, and DME manufacturers through field representatives, an online request-quote system, and a 24/7 patient support hotline staffed by registered nurses. The company is incorporated in Kansas, governed under Kansas law, and operates as an independent publicly traded entity with no parent company; it is covered by four sell-side analysts with a consensus "Buy" rating and a recent Roth MKM price target of $15.00.

Short descriptiontext

InfuSystem Holdings (NYSE: INFU) is a national healthcare service provider that rents, sells, and services ambulatory infusion pumps and durable medical equipment to hospitals, oncology practices, pain management clinics, and wound care providers across the US and Ontario.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersRochester Hills, United States
HQ citystring
Rochester Hills
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices7 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
durable medical equipment, infusion pump services, biomedical equipment repair, wound care therapy, outpatient infusion therapy
Industry4 codes
PRIMARYHLAHAIAF
Infusion Pumps (Ambulatory/Stationary)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Drug Delivery Devices (Injectors, Pumps, Inhalers)
SECONDARYHLAHAIAH
Infusion Sets, Catheters & Pump Consumables
Healthcare & Life Sciences/Medical Devices & Diagnostics/Drug Delivery Devices (Injectors, Pumps, Inhalers)
SECONDARYHLAFALAG
Infusion & Home Infusion Pharmacy Services
Healthcare & Life Sciences/Healthcare Providers & Systems/Pharmacy & Medication Management Services
SECONDARYHLAFABAF
Infusion Therapy Centers (Outpatient)
Healthcare & Life Sciences/Healthcare Providers & Systems/Ambulatory & Outpatient Care Centers
NAICS code4 codes
  • Ambulatory Health Care Services621
  • Surgical Appliance and Supplies Manufacturing339113
  • Measuring, Dispensing, and Other Pumping Equipment Manufacturing333914
  • All Other Outpatient Care Centers621498
SIC code3 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Wholesale-Medical, Dental & Hospital Equipment & Supplies5047
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Durable Medical Equipment Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Patient Services (DME Rentals)
TypeSubscription Recurring
Description

Rental of ambulatory infusion pumps and durable medical equipment to healthcare providers and patients, generating recurring revenue through monthly rental agreements. Includes wound care services with NPWT systems where wound care revenue more than doubled year-over-year.

infusystem.com
2Device Solutions (Sales)
TypeOne Time License
Description

Sale of new and pre-owned infusion pumps, disposables, and consumable products. Q1 2026 Device Solutions revenue was $11.6 million, down 16.9% year-over-year due to strategic restructuring of low-margin business.

stocktitan.net
3Biomedical Services
TypeProfessional Services
Description

On-site and depot repair and maintenance services for medical equipment including infusion pumps, patient monitors, ESUs, and other biomedical devices. Includes preventive maintenance and warranty services completed to factory specifications.

infusystem.com
4Billing Services
TypeProfessional Services
Description

Comprehensive billing and reimbursement services for healthcare providers related to DME and infusion therapy services

biospace.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details2 tiers
1Medicare Patient Treatment - Per Treatment Pricing
ModelUnit PricingBilling cadenceMonthly
Notes

$79.00 per Medicare patient treatment. Price may increase annually with 30 days advance notice.

infusystem.com
2Custom Quoting for Equipment and Services
ModelOtherBilling cadenceMulti-year contract
Notes

Quote-based pricing for infusion pump sales, rentals, biomedical services, and disposable products. Contact sales team via 1-800-962-9656 or request quote form.

infusystem.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 4 records shown
1DeviceHub®
Description

Device management platform for tracking and managing medical equipment

infusystem.com
+3 more records
Core offering1 text field

InfuSystem provides medical-grade ambulatory and large-volume infusion pumps for sale, rental, and lease, along with disposables, integrated therapy services (oncology, pain management, wound care/NPWT), and on-site and depot biomedical equipment repair services. The company also delivers clinical, billing and reimbursement support, plus proprietary platforms (DeviceHub, Express, InfuBLOCK Dashboard) for device and patient management.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • Record full year 2025 revenue of $143.4 million, up 6% year-over-year
+6 more records
Product overview1 text field

InfuSystem Holdings is a national healthcare service provider that operates through three business segments: Patient Services (providing integrated therapy services for oncology, pain management, and wound care), Device Solutions (offering ambulatory infusion pump sales, rentals, leasing, and disposable medical products), and biomedical services (on-site and depot maintenance/repair for medical equipment). The company serves durable medical equipment manufacturers and healthcare providers, delivering ambulatory pumps, supplies, and related clinical and billing services to practices and patients nationwide. The product portfolio includes pump equipment across multiple technology categories (ambulatory, enteral, pole-mounted, syringe pumps), therapy-specific offerings (oncology, pain management, wound care including NPWT systems), biomedical services, and patient-facing platforms (Express, InfuBLOCK Dashboard, DeviceHub).

Product and service18 records
1Infusion Pump Sales & Rental
CategoryEquipment Sales & Rental
Description

Provides new and pre-owned ambulatory and large-volume infusion pumps from multiple brands for sale, rental, and lease to healthcare providers.

2Infusion Pump Financing
CategoryFinancial Services
Description

Offers lease financing options enabling healthcare providers to acquire ambulatory infusion pumps through structured lease arrangements.

3Disposable Products
CategoryMedical Supplies
Description

Supplies disposable medical products including pump tubing, IV extension tubing, Huber needles, and other single-use items used with infusion therapy.

4Equipment Catalog - Ambulatory and Pole-Mounted Infusion Pumps
CategoryEquipment Catalog
Description

Extensive catalog of ambulatory infusion pump models and large-volume pole-mounted pumps, plus syringe and enteral pumps, available for sale, rental, and lease across all major pump technology classes.

5Chemo Mouthpiece
CategoryMedical Device Accessory
Description

Mouthpiece product for chemotherapy patients, sold through InfuSystem's equipment catalog.

6On-site Biomedical Services
CategoryBiomedical Services
Description

On-site repair and preventive maintenance services for medical equipment including infusion pumps, patient monitors, ESUs, and other biomedical devices, delivered at customer facilities.

7Depot Biomedical Services
CategoryBiomedical Services
Description

Depot-based repair and maintenance services for medical equipment, completed to factory specifications.

8DeviceHub® Device Management Platform
CategoryHealthcare Technology Platform
Description

Device management platform providing inventory tracking, maintenance scheduling, and equipment lifecycle management for medical devices across customer deployments.

9Oncology Therapy Services
CategoryIntegrated Therapy Services
Description

Integrated oncology therapy services supporting clinic-to-home patient care, with ambulatory infusion pumps, supplies, clinical hotline support, and bundled billing/reimbursement.

10Pain Management Therapy Services
CategoryIntegrated Therapy Services
Description

Pain management therapy services providing epidural and IV infusion pumps, nerve block catheters, and postoperative pain pumps with related supplies.

11Wound Care Therapy Services
CategoryIntegrated Therapy Services
Description

Wound care therapy services bundling NPWT systems, advanced wound care products, and the Home First Wound Care Kit to support chronic wound treatment at home.

12NPWT Systems (Negative Pressure Wound Therapy)
CategoryWound Care Equipment
Description

Negative pressure wound therapy systems available through the wound care lease program for advanced wound care treatment.

13Home First® Wound Care Kit
CategoryWound Care Product
Description

Home-based wound care kit enabling patients to receive wound care treatment in their homes, supporting the clinic-to-home care model.

14Advanced Wound Care Products
CategoryWound Care Product
Description

Comprehensive line of advanced wound care products supporting chronic wound treatment.

15Skin and Wound Supportive Care Products
CategoryWound Care Product
Description

Supportive care products for skin and wound treatment that complement the wound care therapy services.

16Safen® Single-Use Line Identification Tags
CategoryMedical Device Accessory
Description

FDA-registered, single-use disposable tags designed to reduce infusion line identification errors across care settings; recognized as the industry standard for infusion therapy labeling.

17Radiaderm™ Skincare System (R1 Cooling Gel and R2 Soothing Lotion)
CategorySkincare Product
Description

Advanced skin care products (R1 Cooling Gel and R2 Soothing Lotion system packs) for cooling, soothing, and protecting the skin of radiation therapy patients during and after treatment. InfuSystem is the USA distributor.

18Billing & Insurance Services
CategoryRevenue Cycle Services
Description

Billing, insurance verification, and reimbursement support services for healthcare providers related to durable medical equipment and infusion therapy services.

Scale indicator15 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2025-01-01
Description

Strategic partnership with GE Healthcare for biomedical services. InfuSystem intentionally restructured its largest biomedical services contract with GE Healthcare in late 2025, reducing revenue by $7.1 million to eliminate low-margin business and improve cash flow. This contract restructuring was a strategic decision to prioritize profitable revenue streams.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1McKesson
TypeBroad incumbent
Description

Largest US pharmaceutical and medical-surgical distributor. Broad incumbent in medical equipment/supplies wholesale with adjacent home infusion distribution capabilities.

TypeDirect peer
Description

Provider of home medical equipment and respiratory/home infusion services. Directly comparable DME/home-care business model; InfuSystem's investor materials even benchmark FCF yield against Viemed.

TypeDirect peer
Description

Largest independent provider of home and alternate-site infusion services in the US. Directly comparable outpatient/home infusion therapy business serving oncology, anti-infective, and chronic disease patients.

TypeDirect peer
Description

National provider of home medical equipment, medical supplies, and related services including sleep, respiratory, and DME. Comparable multi-vertical DME distribution and rental model.

TypeDirect peer
Description

Owens & Minor acquired Apria, a national home medical equipment and infusion supplies provider. Comparable DME distribution plus home infusion therapy services across hospital and home settings.

TypeDirect peer
Description

Provider of home health, hospice, and medical solutions including enteral/infusion supplies. Overlapping home-based therapy services and DME distribution into pediatric and adult patient populations.

TypeDirect peer
Description

Home health and hospice provider with home-based therapy offerings including infusion. Comparable clinic-to-home care model with multi-state footprint.

TypeBroad incumbent
Description

Holds VITAS Healthcare (hospice) and Roto-Rooter; a broader healthcare services platform with adjacent home-based care exposure. Less direct overlap with infusion pumps but comparable healthcare services investor profile.

TypeBroad incumbent
Description

Large distributor of medical, dental, and animal health products. Broad incumbent in medical equipment/supplies wholesale that serves many of the same provider customers as InfuSystem.

TypeBroad incumbent
Description

Global medical device manufacturer that produces infusion pumps (e.g., MiniMed, Alaris legacy products) and competes in adjacent pump categories. Broad incumbent in drug-delivery devices.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

InfuSystem Holdings

Durable Medical Equipment Servicesinfusystem.com

InfuSystem Holdings (NYSE: INFU) is a national healthcare service provider that rents, sells, and services ambulatory infusion pumps and durable medical equipment to hospitals, oncology practices, pain management clinics, and wound care providers across the US and Ontario.

What InfuSystem Holdings does

InfuSystem Holdings, Inc. (NYSE: INFU) is a national healthcare service provider that delivers integrated therapy services, biomedical repair and maintenance, and durable medical equipment (DME) to healthcare providers, DME manufacturers, and patients across the United States and Ontario, Canada. Operating for approximately 40 years and headquartered in Rochester Hills, Michigan, the company is structured around three reporting segments: Patient Services (recurring DME rentals focused on oncology, pain management, and wound care), Device Solutions (one-time sales of new and pre-owned ambulatory and pole-mounted infusion pumps, disposables, and accessories), and Biomedical Services (on-site and depot repair of infusion pumps, patient monitors, ESUs, and related equipment). Its primary customer base spans hospitals, oncology practices, pain management clinics, wound care providers, and DME manufacturers. In FY2025 the company generated record revenue of $143.4 million (+6% YoY), record adjusted EBITDA of $31.5 million (+24% YoY), and record operating cash flow of $24.4 million (+19% YoY), with a Q4 2025 adjusted EBITDA margin of 24.3%.

The company has built a proprietary technology stack including DeviceHub® for medical device lifecycle management, Express™ for patient and facility billing, and the InfuBLOCK Dashboard™ for therapy monitoring — platforms that integrate equipment tracking, maintenance scheduling, and reimbursement workflows into a single operational layer for healthcare providers. The product portfolio covers a broad catalog of FDA-registered ambulatory infusion pumps (CADD, Curlin, Sapphire, BodyGuard), large-volume pole-mounted pumps (BD Alaris, Plum 360, SIGMA Spectrum), syringe and enteral pumps, NPWT wound care systems, the Home First® Wound Care Kit, Safen® single-use line identification tags (recognized as the industry standard for infusion line labeling), the Chemo Mouthpiece, and the Radiaderm® radiation therapy skincare line. A new ERP system was implemented on March 1, 2026, with management projecting approximately $2 million in annual net savings. Distribution is delivered through six regional Centers of Excellence across Michigan, Kansas, California, Massachusetts, Texas, and Ontario, supported by direct field sales representatives.

The revenue model combines recurring monthly DME rental income, one-time equipment and consumable sales, and professional service fees for biomedical maintenance and billing/insurance support. Pricing is predominantly quote-based for commercial business, with Medicare patient treatment pricing standardized at $79.00 per treatment. Go-to-market is sales-led, targeting hospitals, clinics, oncology practices, pain management practices, wound care providers, and DME manufacturers through field representatives, an online request-quote system, and a 24/7 patient support hotline staffed by registered nurses. The company is incorporated in Kansas, governed under Kansas law, and operates as an independent publicly traded entity with no parent company; it is covered by four sell-side analysts with a consensus "Buy" rating and a recent Roth MKM price target of $15.00.

InfuSystem Holdings firmographics

Firmographics
Name
InfuSystem Holdings
Legal name
InfuSystem, Inc.
Website
https://infusystem.com
Company type
Public
Founded year
1985
Operating status
Operating
Headcount range
251–500 employees
Short description
InfuSystem Holdings (NYSE: INFU) is a national healthcare service provider that rents, sells, and services ambulatory infusion pumps and durable medical equipment to hospitals, oncology practices, pain management clinics, and wound care providers across the US and Ontario.
Ownership category
akta.pro rank

InfuSystem Holdings industry classification

Industry
Product category
Durable Medical Equipment Services
NAICS
Ambulatory Health Care Services (621), Surgical Appliance and Supplies Manufacturing (339113), Measuring, Dispensing, and Other Pumping Equipment Manufacturing (333914), All Other Outpatient Care Centers (621498)
SIC
Surgical & Medical Instruments & Apparatus (3841), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLAHAIAF
Infusion Pumps (Ambulatory/Stationary)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Drug Delivery Devices (Injectors, Pumps, Inhalers)
SECONDARYHLAHAIAH
Infusion Sets, Catheters & Pump Consumables
Healthcare & Life Sciences/Medical Devices & Diagnostics/Drug Delivery Devices (Injectors, Pumps, Inhalers)
SECONDARYHLAFALAG
Infusion & Home Infusion Pharmacy Services
Healthcare & Life Sciences/Healthcare Providers & Systems/Pharmacy & Medication Management Services
SECONDARYHLAFABAF
Infusion Therapy Centers (Outpatient)
Healthcare & Life Sciences/Healthcare Providers & Systems/Ambulatory & Outpatient Care Centers

Keywords

  • Durable medical equipment
  • Infusion pump services
  • Biomedical equipment repair
  • Wound care therapy
  • Outpatient infusion therapy

Where InfuSystem Holdings is headquartered

Location

Headquarters

HQ city
Rochester Hills
HQ country
United States
HQ region
North America

Offices7 records

Markets served

InfuSystem Holdings business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Patient Services (DME Rentals): Rental of ambulatory infusion pumps and durable medical equipment to healthcare providers and patients, generating recurring revenue through monthly rental agreements. Includes wound care services with NPWT systems where wound care revenue more than doubled year-over-year.
  2. Device Solutions (Sales): Sale of new and pre-owned infusion pumps, disposables, and consumable products. Q1 2026 Device Solutions revenue was $11.6 million, down 16.9% year-over-year due to strategic restructuring of low-margin business.
  3. Biomedical Services: On-site and depot repair and maintenance services for medical equipment including infusion pumps, patient monitors, ESUs, and other biomedical devices. Includes preventive maintenance and warranty services completed to factory specifications.
  4. Billing Services: Comprehensive billing and reimbursement services for healthcare providers related to DME and infusion therapy services

Pricing tiers

ModelBillingPrice
Unit PricingMonthlyMedicare Patient Treatment - Per Treatment Pricing
OtherMulti-year contractCustom Quoting for Equipment and Services

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

InfuSystem Holdings product offering

Product offering

Core offering

InfuSystem provides medical-grade ambulatory and large-volume infusion pumps for sale, rental, and lease, along with disposables, integrated therapy services (oncology, pain management, wound care/NPWT), and on-site and depot biomedical equipment repair services. The company also delivers clinical, billing and reimbursement support, plus proprietary platforms (DeviceHub, Express, InfuBLOCK Dashboard) for device and patient management.

Product overview

InfuSystem Holdings is a national healthcare service provider that operates through three business segments: Patient Services (providing integrated therapy services for oncology, pain management, and wound care), Device Solutions (offering ambulatory infusion pump sales, rentals, leasing, and disposable medical products), and biomedical services (on-site and depot maintenance/repair for medical equipment). The company serves durable medical equipment manufacturers and healthcare providers, delivering ambulatory pumps, supplies, and related clinical and billing services to practices and patients nationwide. The product portfolio includes pump equipment across multiple technology categories (ambulatory, enteral, pole-mounted, syringe pumps), therapy-specific offerings (oncology, pain management, wound care including NPWT systems), biomedical services, and patient-facing platforms (Express, InfuBLOCK Dashboard, DeviceHub).

Differentiator

Problem solved

Functional benefit

Brands

  • DeviceHub®: Device management platform for tracking and managing medical equipment
  • Express™
  • InfuBLOCK Dashboard™
  • Radiaderm™

Products and services

  • Infusion Pump Sales & Rental Provides new and pre-owned ambulatory and large-volume infusion pumps from multiple brands for sale, rental, and lease to healthcare providers.
  • Infusion Pump Financing Offers lease financing options enabling healthcare providers to acquire ambulatory infusion pumps through structured lease arrangements.
  • Disposable Products Supplies disposable medical products including pump tubing, IV extension tubing, Huber needles, and other single-use items used with infusion therapy.
  • Equipment Catalog - Ambulatory and Pole-Mounted Infusion Pumps Extensive catalog of ambulatory infusion pump models and large-volume pole-mounted pumps, plus syringe and enteral pumps, available for sale, rental, and lease across all major pump technology classes.
  • Chemo Mouthpiece Mouthpiece product for chemotherapy patients, sold through InfuSystem's equipment catalog.
  • On-site Biomedical Services On-site repair and preventive maintenance services for medical equipment including infusion pumps, patient monitors, ESUs, and other biomedical devices, delivered at customer facilities.
  • Depot Biomedical Services Depot-based repair and maintenance services for medical equipment, completed to factory specifications.
  • DeviceHub® Device Management Platform Device management platform providing inventory tracking, maintenance scheduling, and equipment lifecycle management for medical devices across customer deployments.
  • Oncology Therapy Services Integrated oncology therapy services supporting clinic-to-home patient care, with ambulatory infusion pumps, supplies, clinical hotline support, and bundled billing/reimbursement.
  • Pain Management Therapy Services Pain management therapy services providing epidural and IV infusion pumps, nerve block catheters, and postoperative pain pumps with related supplies.
  • Wound Care Therapy Services Wound care therapy services bundling NPWT systems, advanced wound care products, and the Home First Wound Care Kit to support chronic wound treatment at home.
  • NPWT Systems (Negative Pressure Wound Therapy) Negative pressure wound therapy systems available through the wound care lease program for advanced wound care treatment.
  • Home First® Wound Care Kit Home-based wound care kit enabling patients to receive wound care treatment in their homes, supporting the clinic-to-home care model.
  • Advanced Wound Care Products Comprehensive line of advanced wound care products supporting chronic wound treatment.
  • Skin and Wound Supportive Care Products Supportive care products for skin and wound treatment that complement the wound care therapy services.
  • Safen® Single-Use Line Identification Tags FDA-registered, single-use disposable tags designed to reduce infusion line identification errors across care settings; recognized as the industry standard for infusion therapy labeling.
  • Radiaderm™ Skincare System (R1 Cooling Gel and R2 Soothing Lotion) Advanced skin care products (R1 Cooling Gel and R2 Soothing Lotion system packs) for cooling, soothing, and protecting the skin of radiation therapy patients during and after treatment. InfuSystem is the USA distributor.
  • Billing & Insurance Services Billing, insurance verification, and reimbursement support services for healthcare providers related to durable medical equipment and infusion therapy services.

Quantifiable outcome

  • Record full year 2025 revenue of $143.4 million, up 6% year-over-year
  • +6 more outcomes

Companies that use InfuSystem Holdings

Customer profile

Named customers5 records

Segments4 records

Ideal customer profiles4 records

InfuSystem Holdings technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

Feature4 records

InfuSystem Holdings partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • GE HealthcaremajorStrategic or Co-development Partner · 1 January 2025Strategic partnership with GE Healthcare for biomedical services. InfuSystem intentionally restructured its largest biomedical services contract with GE Healthcare in late 2025, reducing revenue by $7.1 million to eliminate low-margin business and improve cash flow. This contract restructuring was a strategic decision to prioritize profitable revenue streams.

Scale indicators15 records

Recent moves6 records

Expansion highlights6 records

InfuSystem Holdings competitors and assessment

Company assessment

Broad incumbents

  • McKesson: Largest US pharmaceutical and medical-surgical distributor. Broad incumbent in medical equipment/supplies wholesale with adjacent home infusion distribution capabilities.
  • Chemed Corp (VITAS Healthcare): Holds VITAS Healthcare (hospice) and Roto-Rooter; a broader healthcare services platform with adjacent home-based care exposure. Less direct overlap with infusion pumps but comparable healthcare services investor profile.
  • Henry Schein: Large distributor of medical, dental, and animal health products. Broad incumbent in medical equipment/supplies wholesale that serves many of the same provider customers as InfuSystem.
  • Medtronic: Global medical device manufacturer that produces infusion pumps (e.g., MiniMed, Alaris legacy products) and competes in adjacent pump categories. Broad incumbent in drug-delivery devices.

Direct peers

  • Viemed Healthcare: Provider of home medical equipment and respiratory/home infusion services. Directly comparable DME/home-care business model; InfuSystem's investor materials even benchmark FCF yield against Viemed.
  • Option Care Health: Largest independent provider of home and alternate-site infusion services in the US. Directly comparable outpatient/home infusion therapy business serving oncology, anti-infective, and chronic disease patients.
  • AdaptHealth: National provider of home medical equipment, medical supplies, and related services including sleep, respiratory, and DME. Comparable multi-vertical DME distribution and rental model.
  • Owens & Minor (Apria Healthcare): Owens & Minor acquired Apria, a national home medical equipment and infusion supplies provider. Comparable DME distribution plus home infusion therapy services across hospital and home settings.
  • Aveanna Healthcare: Provider of home health, hospice, and medical solutions including enteral/infusion supplies. Overlapping home-based therapy services and DME distribution into pediatric and adult patient populations.
  • Enhabit: Home health and hospice provider with home-based therapy offerings including infusion. Comparable clinic-to-home care model with multi-state footprint.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

InfuSystem Holdings social profiles

Digital presence

InfuSystem Holdings compliance and trust

Trust signal

Compliance1 record

InfuSystem Holdings financial estimates

Financial estimate

Revenue estimate

Valuation estimate

InfuSystem Holdings leadership team

Management profile

Number of profiles

Profiles4 records

InfuSystem Holdings funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

InfuSystem Holdings M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about InfuSystem Holdings

What does InfuSystem Holdings do?

InfuSystem provides medical-grade ambulatory and large-volume infusion pumps for sale, rental, and lease, along with disposables, integrated therapy services (oncology, pain management, wound care/NPWT), and on-site and depot biomedical equipment repair services. The company also delivers clinical, billing and reimbursement support, plus proprietary platforms (DeviceHub, Express, InfuBLOCK Dashboard) for device and patient management.

Is InfuSystem Holdings a public or private company?

InfuSystem Holdings is a public company. It is classified as public and is currently operating.

When was InfuSystem Holdings founded?

InfuSystem Holdings was founded in 1985. It employs 251 to 500 people.

Where is InfuSystem Holdings based?

InfuSystem Holdings is headquartered in Rochester Hills, United States, in the North America region.

How does InfuSystem Holdings make money?

Four revenue lines are on record. Patient Services (DME Rentals) is the primary driver. The others are device Solutions (Sales), biomedical Services and billing Services.

Who are InfuSystem Holdings's main competitors?

Broad incumbents on record are McKesson, Chemed Corp (VITAS Healthcare), Henry Schein and Medtronic. Direct peers are Viemed Healthcare, Option Care Health, AdaptHealth, Owens & Minor (Apria Healthcare), Aveanna Healthcare and Enhabit.

Does InfuSystem Holdings have an API?

No public API is recorded for InfuSystem Holdings.

What industry is InfuSystem Holdings in?

InfuSystem Holdings's product category is Durable Medical Equipment Services. Its primary akta.pro industry code is HLAHAIAF, Infusion Pumps (Ambulatory/Stationary), with a secondary code of HLAHAIAH, Infusion Sets, Catheters & Pump Consumables. Its NAICS code is 621 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
The future of tradingInfuSystem Q3 net income rises 40% to $3.16 millionInfuSystem reported Q3 2026 net income of $3.16 million, up 40% year over year. Net revenues rose to $37.59 million, with Patient Services up 15% to $25.81 million and Device Solutions down 17% to $11.78 million. ERP-related billing disruptions created about $5 million in temporary working capital pressure, with collection trends improving into October.TradingViewInfuSystem Holdings to Report Q3 2026 Results November 3 Before Market OpenInfuSystem Holdings will report its Q3 2026 financial results before market open on November 3. The company will hold an investor conference call at 9:00 a.m. Eastern Time, with a replay available through February 3, 2027.Ticker ReportComparing InfuSystem (NYSE:INFU) & Pediatrix Medical Group (NYSE:MD)Pediatrix Medical Group and InfuSystem are compared on profitability, risk, and analyst ratings. InfuSystem has a stronger consensus rating and higher upside, while Pediatrix has higher revenue and lower valuation. Analysts favor InfuSystem as the more favorable investment.Markets DailyHead-To-Head Comparison: AirSculpt Technologies (NASDAQ:AIRS) vs. InfuSystem (NYSE:INFU)AirSculpt Technologies and InfuSystem are compared on profitability, valuation, risk, and analyst recommendations. InfuSystem beats AirSculpt on 9 of 14 factors, but AirSculpt has higher upside potential. Analysts rate InfuSystem more favorably, with a consensus price target of $16.67 versus $4.50 for AirSculpt.Ticker ReportAnalyzing Exagen (NASDAQ:XGN) and InfuSystem (NYSE:INFU)InfuSystem and Exagen are compared on earnings, valuation, and analyst ratings. InfuSystem has higher revenue and earnings, while Exagen trades at a lower P/E. Analysts favor InfuSystem with a higher consensus upside.Markets DailyInfuSystem (NYSE:INFU) vs. Cosmos Health (NASDAQ:COSM) Head to Head ComparisonInfuSystem beats Cosmos Health on 12 of 14 factors, including higher revenue ($143.34M vs $65.27M) and profitability. InfuSystem has a stronger consensus rating and a price target implying 36.17% upside, while Cosmos Health is more volatile and unprofitable.Seeking AlphaInfuSystems: More Upside Ahead (NYSE:INFU)A shareholder-focused note on InfuSystems (INFU) cites a 24% adjusted EBITDA increase in FY25 and 154% Wound Care revenue growth, alongside record Oncology volumes and Patient Services expansion. The company reports net debt of 0.61x EBITDA, $55.2M liquidity, and a 5% share count reduction in H1. Valuation is described as 7.5x EV/EBITDA and 1.7x EV/S.Ticker ReportDiamond Hill Capital Management LLC Investment Advisor Takes $4.72 Million Position in InfuSystem Holdings, Inc. $INFUDiamond Hill Capital Management LLC initiated a $4.72 million position in InfuSystem Holdings, Inc. during the second quarter, according to its recent 13F filing with the SEC. Additionally, B. Riley Financial upgraded its rating on InfuSystem shares to 'buy' with a $20.00 price target, reflecting positive analyst sentiment alongside other institutional buying activity.Markets DailyInfuSystem (NYSE:INFU) Shares Down 1.8% – What’s Next?InfuSystem Holdings Inc. shares declined 1.8% on Wednesday, trading at $12.24 with reduced volume compared to its average daily activity. B. Riley Financial reaffirmed a buy rating and raised its price target to $20.00, while the company previously authorized a $20 million stock buyback program in May.The Motley FoolInfuSystem (INFU) Q2 2026 Earnings Call TranscriptInfuSystem reported record second quarter 2026 revenue of $36.9 million, driven by growth in patient services and wound care, with a net income of $3.2 million and adjusted EBITDA of $8.6 million. The company highlighted ongoing operational improvements, a successful product launch, and positive forecasts for revenue growth and profit margins, despite revenue reductions from contract restructuring.